发明名称 Cyclic ether DGAT1 inhibitorscyclic ether DGAT1 inhibitors
摘要 The invention relates to compounds of formula (I): useful for treating disorders mediated by acyl coA-diacylglycerol acyl transferase 1 (DGAT1), e.g. metabolic disorders. The invention also provides methods of treating such disorders, and compounds and compositions etc. for their treatment.;
申请公布号 US9108956(B2) 申请公布日期 2015.08.18
申请号 US201314396744 申请日期 2013.04.26
申请人 NOVARTIS AG 发明人 Patel Sejal;Mao Justin;Liu Qian;Harrison Tyler;Duvadie Rohit;Chen Xin;Zecri Frederic
分类号 C07D413/12;C07D417/12 主分类号 C07D413/12
代理机构 代理人 Roth Joshua
主权项 1. A compound according to formula (I) or a salt or solvate thereof: wherein X is O or CH2; Y is O or CH2; wherein one of X and Y is O and the other is CH2; Z1, Z2, Z3 and Z4 are each, independently, N or CH; L is C(O) or absent; and A is a substituted oxazole, thiazole, oxadiazole or thiadiazole substituted with at least one C1-6alkyl, C3-7cycloalkyl or C1-6haloalkyl.
地址 Basel CH